Literature DB >> 22481898

Dietary intake of menaquinone-4 may determine hepatic and pancreatic menaquinone-4 in chickens.

Merete Askim1, Anna Haug, Gaut Gadeholt.   

Abstract

OBJECTIVE: The aim of this study was to determine the biological effects of natural dietary intake of vitamin K as phylloquinone (K(1)) and menaquinone-4 (MK-4) and a control diet also containing menadione (K(3)) on levels of K(1) and total MK-4 (menaquinone-4) and menaquinone-4-2,3-epoxide (MK-4O)) in liver and pancreas, and on femur bending resistance in a fast-growing animal model.
DESIGN: Chickens were fed four wheat-based diets from day 11 to day 22 after hatching. The diets contained different combinations of fat sources: rapeseed oil, animal rendered fat, soybean oil and hydrogenated soybean oil. Concentration of K(1) in the three experimental diets was 120 ng/g whereas MK-4 levels were 23, 52 and 63 ng/g respectively. The control diet contained 157 ng K(1)/g, 75 ng MK-4/g and 2.250 ng K(3)/g.
RESULTS: Growth rates and femur strength confirmed adequate supply of nutrients and vitamin K in the test groups. There were no significant differences in femur bending resistance among the test groups, but these were higher than the control. K(1), MK-4 and MK-4O were found in liver. In pancreas, mainly MK-4O was found with small amounts of MK-4, but none had content of K(1). In the test groups the hepatic levels of MK-4 and MK-4O reflected the dietary intake of MK-4.
CONCLUSION: The chickens were in good health with good bone resistance without supplements of K(3) in the feed, but at least a natural content of 23 ng MK-4/g feed. Liver and pancreas appears to use MK-4 in different ways.

Entities:  

Keywords:  Menaquinone-4; chicken; diet; liver; pancreas

Year:  2012        PMID: 22481898      PMCID: PMC3319137          DOI: 10.3402/fnr.v56i0.5380

Source DB:  PubMed          Journal:  Food Nutr Res        ISSN: 1654-661X            Impact factor:   3.894


It has been shown experimentally that oral absorption of phylloquinone (vitamin K1; K1) is higher when it is taken as a pharmaceutical preparation than when it is taken as part of a meal in which the vitamin is naturally present (1). Dietary K1 as well as the closely related menaquinone-4 (MK-4) are transported with different lipoproteins in the blood (2). Different tissues have different mechanisms of uptake of vitamin-carrying plasma proteins, resulting in differences in the equilibrium concentrations of K1 and MK-4 (3, 4). There is also evidence that MK-4 can be synthesized in tissues from menadione (vitamin K3; K3), either as such (5), derived from K1 (6–9), or by direct substitution (10). In many of these studies the experimental animals were deprived of vitamin K or given overly high doses of K1. Chickens have been bred for high utilization of feed and high rates of growth. During the first 3 weeks of life a typical chicken will increase its body mass by a factor of 20. Chickens cannot perform de novo synthesis of vitamin K; hence the tissue levels of vitamin K measured after the feeding period would in some way have to be related to the dietary intake. Any vitamin K present at the start of experimental feeding would provide only a limited fraction of the total amount present. Liver is the main site of synthesis for vitamin K-dependent coagulation factors and has been shown to possess the apparatus necessary to synthesize MK-4 (5, 7, 9). Pancreas has been reported to have higher values of MK-4 than most other tissues, possibly owing to K1-to-MK-4 conversion (11, 12) and possibly related to the secretion of MK-4 in pancreatic juice (13). In chickens, the activity of epoxide reductase per gram tissue has been found to be 10% of the activity in rats (6), explaining why a high proportion of the vitamin K material of chickens is present as the 2,3-epoxide. The present study was designed to investigate how ordinary dietary doses of vitamin K would influence tissue accumulation of K1 and MK-4. Care was taken to vary only the dietary concentration of MK-4 together with an adequate and stable concentration of K1, and in an identical feed matrix so as to limit any feed-induced variations in bioavailability. For comparison regarding the adequacy of the feeds a control group receiving the standard chicken feed containing additional K3 was included. Vitamin K–dependent carboxylation of bone matrix proteins is regarded as important for bone matrix calcification (14). Bone strength was measured to investigate whether our modest variations in vitamin K content could be detected in this system.

Methods

Chickens

Fifty-seven newly hatched male chickens (Samvirke kylling Norway, Ross 308) from the same hatching farm were used in this experiment conducted at The Norwegian University of Life Sciences. Animal treatment and animal facilities all complied with the Guide for the Care and Use of Laboratory Animals (15). The experimental animal research followed internationally recognized guidelines. All animals were cared for according to Norwegian laws and regulations for experiments with live animals (The Animal Protection Act of December 20th, 1974, and the Animal Protection Ordinance Concerning Experiments with Animals of January 15th, 1996).

Experimental design

The chickens were randomly assigned into one of four dietary 22 day treatments. During the first 10 days each group of 14 to 15 animals were kept in deep littered pens; 75 cm×150 cm. At day 10 they were weighed and individually placed in wire-floored metabolism cages up until day 22. The chickens were raised in an environmentally controlled room. The room temperature was maintained at 32°C from days 0–3, then gradually reduced by 0.5°C per day until day 22. They were exposed to 23 h light and 1 h dark photoperiod days 0–7, the next 2 weeks they were exposed to 2×4 h dark; the dark periods were between 17–21 h and 00–04 h. The chickens had free access to feed and water. Water troughs and wire-floors were cleaned daily, with small possibility of coprophagy. Feed intake and body weight were registered day 11 to day 22. None of the birds were sick or died during the feeding period.

Sampling

At day 22 the chickens were weighed, killed by carbon dioxide narcosis and dissected immediately after death. Organs and limbs were packed in aluminum foil, frozen in liquid nitrogen and stored at −20°C before being analyzed.

Vitamin K in diets

Rapeseed oil was purchased from AFB, Askim, Norway and contained 60% oleic acid, 20% linoleic acid and 10% alpha linolenic acid. Rendered animal fat (RAF) was obtained locally and contained fat from ruminants (about 70%) and pigs (about 30%). The composition of RAF was (by weight): 26% palmitic acid, 18% stearic acid, 36% oleic acid and 8% linoleic acid. Fully hydrogenated soybean oil (HSO), refined to remove K1 and ineffective dihydrophylloquinone together with trans-fatty acids, were purchased from AAK (Aarhus-Karlshamn) Sweden AB. The level of K1 in HSO was less than 10% of the original amount in untreated soybean oil. dihydrophylloquinone was not detected in the oils. All four feeds were wheat based and composed according to guidelines adjusted to the requirements of chickens (Table 1). The feeds were manufactured at ForTek, Aas, Norway, with a matrix type 2.5 mm×46 mm at a rate of 600 kg/h. They had the same basic composition with regard to protein, carbohydrates, minerals and vitamins except vitamin K. All diets contained lipid in the form of oils and solid fats. The control (CTR) feed group contained vitamin K1 from rapeseed oil and soy bean oil; MK-4 from RAF and added K3. The experimental feeds contained natural levels of K1 and MK-4 from RAF, fully HSO or a mixture of animal rendered fat and fully HSO (MIX). The experimental diets contained 2% natural soybean oil to provide a small supplement of K1 (Table 1). K1 content of the control diet was 32% higher than the experimental feeds. The experimental feeds had MK-4 levels from 20 to 50% of the K1 level.
Table 1

Composition of the experimental feeds including levels of vitamin K

IngredientsCTRMIXRAFHSO
Wheat (%)60606060
Soybean meal (%)20202020
Fish meal (%)3333
Rapeseed oil (%)5000
Animal Rendered fat (%)5480
Soybean oil (%)0222
Hydrogenated soybean oil (%)0408
Mineral mixturea (%)0.150.150.150.15
Vitamin mixturea (%)0.080.080.080.08
MK-4 (ng/g feed)75.362.551.622.6
K1 (ng/g feed)157.2120.4119.8119.1
K3 ( ng/g feed)2,250

Notes: All feeds contained Monocalcium phosphate 2%; Ground limestone 1.85%; NaCl 0.25%; DL-Methionine 0.4%, L-lysine 0.3%; L-Threonine 0.1%; Choline chloride 0.13% and MgO 6.57×10−3%.

Vitamin and mineral mixture provided the following per kg feed: retinyl acetate, 2.7 mg; cholecalsiferol, 0.07 mg; DL-alpha tocopheryl acetate, 38 mg; pyridoxine, 3.4 mg; riboflavin, 9 mg; Ca-pantothenate, 12.5 mg; biotin, 0.19 mg; thiamine, 1.9 mg; niacin, 37.5 mg; cobalamine, 0.02 mg; folic acid, 1.5 mg; choline chloride, 500 mg; manganese, 75 mg; zinc, 75 mg; iron, 95 mg; cupper, 10 mg; iodine, 0.6 mg; selenium, 0.43 mg.

Composition of the experimental feeds including levels of vitamin K Notes: All feeds contained Monocalcium phosphate 2%; Ground limestone 1.85%; NaCl 0.25%; DL-Methionine 0.4%, L-lysine 0.3%; L-Threonine 0.1%; Choline chloride 0.13% and MgO 6.57×10−3%. Vitamin and mineral mixture provided the following per kg feed: retinyl acetate, 2.7 mg; cholecalsiferol, 0.07 mg; DL-alpha tocopheryl acetate, 38 mg; pyridoxine, 3.4 mg; riboflavin, 9 mg; Ca-pantothenate, 12.5 mg; biotin, 0.19 mg; thiamine, 1.9 mg; niacin, 37.5 mg; cobalamine, 0.02 mg; folic acid, 1.5 mg; choline chloride, 500 mg; manganese, 75 mg; zinc, 75 mg; iron, 95 mg; cupper, 10 mg; iodine, 0.6 mg; selenium, 0.43 mg.

Vitamin K analysis

Vitamin K in liver, pancreas and feeds were analyzed by HPLC using a C-18 reversed phase column and fluorometric detection after postcolumn electrochemical reduction according to Thijssen et al. (16).

Testing of bone strength

The right femur was thawed gently and dissected free of muscle. Bending resistance was tested in a TA-XT2 texture analyzer from Stable Micro Systems, Godalming, Surrey, UK (www.stablemicrosystems.com). Probe velocity was at 0.1 mm/s, and the distance between the supports was 32.5 mm. Load-versus-time curves were generated and analyzed by means of Texture Expert Exceed v2.64 software. Bending resistance was calculated from the initial linear segment of the graphs and expressed as N/mm.

Statistical analyses

Statistical calculations (linear regression) on the effect of the four dietary treatments were performed by SPSS 15.0 IBM SPSS, Statistical Analyses Software (http://www.spss.com/), using comparative means by one-way ANOVA and Bonferroni test for assumption of equal variances.

Results

Chicken growth

Weight at day 11 and 22 showed that the chickens in the experimental groups ate slightly more and the RAF and HSO group grew significantly faster than the MIX and CTR groups indicating a satisfactory nutritional status (Table 2).
Table 2

Information on feed and weight of the chicken from day 11 to day 22

CTRMIXRAFHSO
n=number of chickens15141414
Chicken weight day 11 (g)268 (18)a,c,d243 (13)b,d274 (16)a,c256 (13)a,b,d
Chicken weight day 22 (g)800 (84)a827 (48)a939 (68)b936 (63)b
Liver weight (g)28 (3)a,b27 (3)a30 (3)b30 (5)b
Feed intake (g)680 (72)a701 (41)a,b746 (51)b766 (64)b
K1 intake (µg)107 (11)a84 (5)b90 (6)b92 (8)b
MK-4-intake (µg)51 (5)a44 (3)b38 (3)c17 (1)d
K1 intake (µg)1,530

Notes: Values are means and SD.

Means with different letters within the same row are significantly different at the 5% level.

Information on feed and weight of the chicken from day 11 to day 22 Notes: Values are means and SD. Means with different letters within the same row are significantly different at the 5% level. Total amount of MK-4 eaten by the chicken was significantly different, being highest in the CTR group and lowest in the HSO group, while for K1 no difference between experimental group but significantly higher in the control group (Table 2).

Vitamin K in liver and pancreas

Pancreas had higher vitamin K concentration than liver (Table 3). In liver, MK-4 was the most abundant vitamer, while in pancreas MK-4O was the main vitamer. K1 was not detected in pancreas (Table 3). The association between the amounts of MK-4 consumed and MK-4 in liver was statistically significant.
Table 3

Levels of vitamin K in liver and pancreas and femur bending resistance

CTRMIXRAFHSO
Liver
K1 (ng/g)47 (11)a28 (11)b35 (16)a26 (12)b
MK-4 (ng/g)425 (66)a238 (56)b105 (22)c59 (14)d
MK-4O (ng/g)104 (29)a80 (25)b38 (16)c23 (16)d
MK-4/(MK-4+MK-4O)%75 (9)66 (11)64 (14)63 (20)
Pancreas
MK-4O (ng/g)1,158 (617)a522 (351)b316 (186)c118 (61)d
MK-4 (ng/g)59 (86)32 (49)7 (9)11 (9)
MK-4/(MK-4+MK-4O)%5 (13)6 (13)2 (4)9 (9)
Femur
Bending resistance (N/mm)85 (10)a96 (13)b98 (11)b102 (12) b

Notes: Values are means and SD.

Means with different letters within the same row are significantly different at the 5% level.

Levels of vitamin K in liver and pancreas and femur bending resistance Notes: Values are means and SD. Means with different letters within the same row are significantly different at the 5% level. The concentration of total MK-4 and MK-4O in pancreas as well as in liver is associated with MK-4 consumed.

Bone strength

The bending resistance of the femur was slightly higher in the experimental groups than in the control group, with no difference between the experimental groups (Table 3).

Discussion

It has long been known that MK-4 is being synthesized in tissues of animals. Our experimental model seems to suggest that conversion of K1 to MK-4 did not take place in the presence of adequate levels of MK-4 in the feed, not even in the feed group with the lowest level of MK-4 (HSO). In the test groups the hepatic levels of MK-4 and MK-4O reflected the dietary intake of MK-4. Recently, a specific enzyme that converts K1 to MK-4 has been discovered and described (10). The production capacity of this enzyme has not been compared with or distinguished from the menadione prenylation system (5), so published evidence is as yet insufficient for a full quantitative picture of the various sources and pathways of synthesis in normally fed animals. MK-4O was in a different way dependent on the vitamin in the feed. The control group had the highest MK-4O levels in pancreas. This could be related to the supplementary K3 given to that group only. Liver and pancreas appears to use MK-4 in different ways; in liver 1/3 of MK-4 is converted to MK-4O while in pancreas almost all is as MK-4O. The content of K1 in liver was higher in the control group. The feed for this group contained more K1 and K3 was added.

Conclusion

The chickens were in good health with good bone resistance without supplements of K3 in the feed but at least a natural content of 23 ng MK-4/g feed. Liver and pancreas appears to use MK-4 in different ways.
  14 in total

1.  Tissue distribution of K-vitamers under different nutritional regimens in the rat.

Authors:  J E Ronden; H H Thijssen; C Vermeer
Journal:  Biochim Biophys Acta       Date:  1998-01-08

2.  Enzymatic alkylation of menaquinone-o to menaquinones microsomes from chick liver.

Authors:  G H Dialameh; K G Yekundi; R E Olson
Journal:  Biochim Biophys Acta       Date:  1970-12-08

3.  Vitamin K status in human tissues: tissue-specific accumulation of phylloquinone and menaquinone-4.

Authors:  H H Thijssen; M J Drittij-Reijnders
Journal:  Br J Nutr       Date:  1996-01       Impact factor: 3.718

4.  Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme.

Authors:  Kimie Nakagawa; Yoshihisa Hirota; Natsumi Sawada; Naohito Yuge; Masato Watanabe; Yuri Uchino; Naoko Okuda; Yuka Shimomura; Yoshitomo Suhara; Toshio Okano
Journal:  Nature       Date:  2010-10-17       Impact factor: 49.962

5.  Expression of LRP1 by human osteoblasts: a mechanism for the delivery of lipoproteins and vitamin K1 to bone.

Authors:  Andreas Niemeier; Moustapha Kassem; Klaus Toedter; Dorte Wendt; Wolfgang Ruether; Ulrike Beisiegel; Joerg Heeren
Journal:  J Bone Miner Res       Date:  2004-11-01       Impact factor: 6.741

6.  Localization of the menaquinone-0 alkylating enzyme in the smooth reticulum of chicken liver microsomes.

Authors:  F C Lee; R E Olson
Journal:  Biochim Biophys Acta       Date:  1984-06-15

7.  Comparative metabolism and requirement of vitamin K in chicks and rats.

Authors:  B H Will; Y Usui; J W Suttie
Journal:  J Nutr       Date:  1992-12       Impact factor: 4.798

8.  Phylloquinone and menaquinone-4 distribution in rats: synthesis rather than uptake determines menaquinone-4 organ concentrations.

Authors:  H H Thijssen; M J Drittij-Reijnders; M A Fischer
Journal:  J Nutr       Date:  1996-02       Impact factor: 4.798

9.  Conversion of phylloquinone (Vitamin K1) into menaquinone-4 (Vitamin K2) in mice: two possible routes for menaquinone-4 accumulation in cerebra of mice.

Authors:  Toshio Okano; Yuka Shimomura; Makiko Yamane; Yoshitomo Suhara; Maya Kamao; Makiko Sugiura; Kimie Nakagawa
Journal:  J Biol Chem       Date:  2007-12-14       Impact factor: 5.157

10.  Menadione is a metabolite of oral vitamin K.

Authors:  Henk H W Thijssen; Lily M T Vervoort; Leon J Schurgers; Martin J Shearer
Journal:  Br J Nutr       Date:  2006-02       Impact factor: 3.718

View more
  1 in total

1.  [Not Available].

Authors: 
Journal:  Food Nutr Res       Date:  2012-04-02       Impact factor: 3.894

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.